UniProt P04233
HLA class II histocompatibility antigen gamma chain (P04233)
HLA class II histocompatibility antigen gamma chain (UniProt P04233): 27 experimental structures on GenesisL1, 13 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P04233
- Protein
- HLA class II histocompatibility antigen gamma chain
- Experimental structures
- 27
- Predicted models
- 0
- Pockets
- 13 · 1 record with a druggable one
Structures
27 records of P04233 in the MolNFT archive: 27 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1A6A | The structure of an intermediate in class II MHC maturation: clip bound to HLA-DR3 | x-ray diffraction | C | — | — |
| 1A6A | The structure of an intermediate in class II MHC maturation: clip bound to HLA-DR3 | x-ray diffraction | C | — | — |
| 1ICF | Crystal structure of MHC class II associated P41 II fragment in complex with cathepsin L | x-ray diffraction | I, J | — | — |
| 1ICF | Crystal structure of MHC class II associated P41 II fragment in complex with cathepsin L | x-ray diffraction | I, J | — | — |
| 1IIE | HLA-dr antigens associated invariant chain | solution nmr | A, B, C | — | — |
| 1IIE | HLA-dr antigens associated invariant chain | solution nmr | A, B, C | — | — |
| 1L3H | NMR structure of P41icf, a potent inhibitor of human cathepsin L | solution nmr | A | — | — |
| 1L3H | NMR structure of P41ICF, a potent inhibitor of human cathepsin L | solution nmr | A | — | — |
| 3PDO | Crystal Structure of HLA-DR1 with CLIP102-120 | x-ray diffraction | C | — | — |
| 3PDO | Crystal structure of HLA-DR1 with CLIP102-120 | x-ray diffraction | C | — | — |
| 3PGC | Crystal Structure of HLA-DR1 with CLIP106-120, flipped peptide orientation | x-ray diffraction | C, F | — | — |
| 3PGC | Crystal structure of HLA-DR1 with CLIP106-120, flipped peptide orientation | x-ray diffraction | C, F | — | — |
| 3PGD | Crystal Structure of HLA-DR1 with CLIP106-120, canonical peptide orientation | x-ray diffraction | C, F | — | — |
| 3PGD | Crystal structure of HLA-DR1 with CLIP106-120, canonical peptide orientation | x-ray diffraction | C, F | — | — |
| 3QXA | HLA-DR1 bound with CLIP peptide | x-ray diffraction | C, F | — | — |
| 3QXA | HLA-DR1 bound with clip peptide | x-ray diffraction | C, F | — | — |
| 3QXD | F54C HLA-DR1 bound with CLIP peptide | x-ray diffraction | F, C | — | — |
| 3QXD | F54C HLA-DR1 bound with clip peptide | x-ray diffraction | F, C | — | — |
| 4AEN | HLA-DR1 with covalently linked CLIP106-120 in reversed orientation | x-ray diffraction | C | — | — |
| 4AEN | HLA-DR1 with covalently linked CLIP106-120 in reversed orientation | x-ray diffraction | C | — | — |
| 4AH2 | HLA-DR1 with covalently linked CLIP106-120 in canonical orientation | x-ray diffraction | B | — | — |
| 4AH2 | HLA-DR1 with covalently linked CLIP106-120 in canonical orientation | x-ray diffraction | B | — | — |
| 4X5W | HLA-DR1 with CLIP102-120(M107W) | x-ray diffraction | C | — | — |
| 4X5W | HLA-DR1 with CLIP102-120(M107W) | x-ray diffraction | C | — | — |
| 8VSP | Cryo-EM structure of human invariant chain in complex with HLA-DQ | electron microscopy | C, F, I | — | 13 (best 0.75) |
| 9CYM | Structure of LAG3 bound to the MHC class II molecule I-A(b) | x-ray diffraction | P | — | — |
| P04233 | AlphaFold monomer V2.0 prediction for HLA class II histocompatibility antigen gamma chain (P04233) | — | — | — |
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.